Answers are grounded in this paper and cite their sources.
Multicentre, open-label phase IV study demonstrates effectiveness of drug combination in bacterial infections, suggesting safe treatment options.
This study was prospectively registered on Clinical Trials Registry, India [CTRI/2022/07/044190] on 20 July, 2022; URL: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=NzA4MTA=&Enc=&userName= .
No takes yet. Share an insight, caveat, or question.
Panda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: